All lobbying filings
ORGANOGENESIS INC.
ORGANOGENESIS INC. filed a Q3 report for ORGANOGENESIS INC. on October 16, 2025.
Lobbying for ORGANOGENESIS INC.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Expenses
$300,000
What this organization spent lobbying with its own staff.
Reported using IRS section 162(e) definitions (method C): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
3
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill
FDA policy on chronic wound healing products
Discussion around new company manufacturing facilities located in Smithfield, Rhode Island.
Bills named in this filing
1